Want to join the conversation?
$ICPT does not expect to generate revenue from product sales unless it successfully close development and obtain marketing approval for one or more of product candidates, which is subject to significant uncertainty. $ICPT sees that it need to raise additional capital to commercialize OCA on a worldwide basis and continue R&D activities.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.